Lifecare ASAOSL:LIFE +1.40%9 PB Ratio is 2.93 as of Jul. 07, 2026, which is 4% below its 10-year median of 3.06. GuruFocus rates OSL:LIFE with a GF Score™ of 9/100 and a GF Value™ of kr0.14 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Lifecare ASA ranks worse than 61.29% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-07), Lifecare ASA's share price is kr0.29. Lifecare ASA's Book Value per Share for the quarter that ended in Mar. 2026 was kr0.10. Hence, Lifecare ASA's PB Ratio of today is 2.93.
The historical rank and industry rank for Lifecare ASA's PB Ratio or its related term are showing as below:
OSL:LIFE'
s PB Ratio Range Over the Past 10 Years
Min: 1.41 Med: 3.06 Max: 11.18
Current: 2.93
During the past 11 years, Lifecare ASA's highest PB Ratio was 11.18. The lowest was 1.41. And the median was 3.06.
OSL:LIFE's PB Ratio is ranked worse than 61.29% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.065
vs OSL:LIFE: 2.93
During the past 12 months, Lifecare ASA's average Book Value Per Share Growth Rate was -91.60% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Lifecare ASA was 132.90% per year. The lowest was -3.40% per year. And the median was 39.65% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Lifecare ASA PB Ratio Related Terms
Lifecare ASA PB Ratio Historical Data
* Premium members only.
The historical data trend for Lifecare ASA's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Lifecare ASA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lifecare ASA PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lifecare ASA's PB Ratio distribution charts can be found below:
* The bar in red indicates where Lifecare ASA's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Lifecare ASA's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Lifecare ASA (OSL:LIFE) has a PB Ratio of 2.93 as of Jul. 07, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Lifecare ASA and its competitors. This is near median its historical median of 3.06. Over the past decade, Lifecare ASA's PB Ratio has ranged from 1.41 to 11.18. According to the industry distribution chart, Lifecare ASA ranks #483 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 61.3%.
Is Lifecare ASA's PB Ratio too high?
Lifecare ASA's current PB Ratio of 2.93 is near median its 10-year median of 3.06. Over the past 10 years, this metric has ranged from a low of 1.41 to a high of 11.18. The Medical Devices & Instruments industry median PB Ratio is 2.07. Lifecare ASA's value of 2.93 is 41.9% above this industry median. Based on the distribution chart, Lifecare ASA ranks #483 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Lifecare ASA has a GF Score™ of 9/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lifecare ASA's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lifecare ASA ranks #483 out of 788 companies for PB Ratio. This places Lifecare ASA in the lower half of its industry. The industry median PB Ratio is 2.07. Lifecare ASA's value of 2.93 is 41.9% above this benchmark. Historically, Lifecare ASA's own PB Ratio has ranged from 1.41 to 11.18 over the past decade. While the company's 10-year median is 3.06 vs. the industry median of 2.07, Lifecare ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.07, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lifecare ASA's current PB Ratio of 2.93 is 41.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Lifecare ASA and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lifecare ASA's current PB Ratio is 2.93, which is near median its own 10-year median of 3.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecare ASA stock overvalued right now?
Based on GuruFocus' analysis, Lifecare ASA (OSL:LIFE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.14, compared to a current price of kr0.29 — trading 107.1% above its estimated fair value. The current PB Ratio is 2.93, which is near median its 10-year median of 3.06 and 41.9% above the Medical Devices & Instruments industry median of 2.07. Lifecare ASA's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Lifecare ASA (OSL:LIFE), the current PB Ratio is 2.93 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lifecare ASA (OSL:LIFE) Overvalued in 2026?
Based on GuruFocus' analysis, Lifecare ASA stock appears to be overvalued.
The current stock price of kr0.29 is trading 107.1% above its estimated GF Value™ of kr0.14.
GuruFocus considers Lifecare ASA to be Significantly Overvalued.
Key valuation signals for OSL:LIFE:
PB Ratio: 2.93 (near median its 10-year median of 3.06)
GF Value™: kr0.14 vs. price of kr0.29 (107.1% above fair value)
Industry Position: 41.9% above the Medical Devices & Instruments median (#483 of 788)
No single metric tells the full story. See the OSL:LIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. It is focused on advancing continuous glucose monitoring systems and uses osmotic pressure as a sensing method. Its technology can be applied to detect and monitor various analytes and molecules in humans and animals. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.
9GF Score
Get the complete analysis for OSL:LIFE
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:LIFE has been successfully added to your 
